Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Vaccines

Free Subscription Articles published in J Virol Retrieve available abstracts of 112 articles: HTML format Text format

Single Articles

May 2012
1. JIMENEZ DE OYA N , Escribano-Romero E, Blazquez AB, Lorenzo M, et al
   CHARACTERIZATION OF HEPATITIS E VIRUS (HEV) RECOMBINANT ORF2 PROTEINS EXPRESSED BY VACCINIA VIRUSES.
   J Virol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. LIU J , Li H, Iampietro MJ, Barouch DH, et al
   Accelerated Heterologous Adenovirus Prime-Boost SIV Vaccine in Neonatal Rhesus Monkeys.
   J Virol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. FLATZ L , Cheng C, Wang L, Foulds K, et al
   Gene-based vaccination with a mis-matched envelope protects against simian immunodeficiency virus infection in non-human primates.
   J Virol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. LIHORADOVA O , Kalveram B, Indran SV, Lokugamage N, et al
   The Dominant-negative Inhibition of dsRNA-dependent Protein Kinase PKR Increases the Efficacy of Rift Valley Fever Virus MP-12 Vaccine.
   J Virol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. YANG L , Song Y, Li X, Huang X, et al
   HIV-1 Virus Like Particles Produced by Stably Transfected Drosophila S2 cells - a Desirable Vaccine Component.
   J Virol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. MOODY MA , Yates NL, Amos JD, Drinker MS, et al
   HIV-1 gp120 Vaccine Induces Affinity Maturation in Both New and Persistent Antibody Clonal Lineages.
   J Virol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. GORANDER S , Harandi AM, Lindqvist M, Bergstrom T, et al
   Glycoprotein G of Herpes Simplex Virus Type 2 as a Novel Vaccine Antigen for Immunity to Genital and Neurological Disease.
   J Virol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. PEARCE MB , Belser JA, Gustin KM, Pappas C, et al
   Seasonal Trivalent Inactivated Influenza Vaccine Protects against 1918 Spanish Influenza Virus in Ferrets.
   J Virol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. MAAN S , Maan NS, Pullinger G, Nomikou K, et al
   The genome sequence of bluetongue virus type 10 from India: evidence for circulation of a Western topotype vaccine strain.
   J Virol. 2012;86:5971-2.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
10. DURAFFOUR S , Andrei G, Topalis D, Krecmerova M, et al
    Mutations Conferring Resistance to Viral DNA Polymerase Inhibitors in Camelpox Virus Give Different Drug-Susceptibility Profiles in Vaccinia Virus.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. HERSPERGER AR , Siciliano NA, Eisenlohr LC
    Comparable Polyfunctionality of Ectromelia- and Vaccinia-specific Murine T-cells Despite Markedly Different in vivo Replication and Pathogenicity.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. IRWIN CR , Evans DH
    Modulation of the myxoma virus plaque phenotype by vaccinia virus F11 protein.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. IZMAILYAN R , Hsao JC, Chung CS, Chen CH, et al
    Integrin beta1 Mediates Vaccinia Virus Entry through Activation of PI3K/Akt Signaling.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. ZHOU F , Wang G, Buchy P, Cai Z, et al
    A Tri-Clade DNA Vaccine Designed on the Basis of a Comprehensive Serologic Study Elicits Neutralizing Antibody Responses against All Clades and Subclades of HPAI H5N1 Viruses.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. CHIUPPESI F , Vannucci L, De Luca A, Lai M, et al
    A lentiviral vector-based, herpes simplex virus type-1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. CLO E , Kracun SK, Nudelman AS, Jensen KJ, et al
    Characterization of the viral O-glycopeptidome: a novel tool of relevance for vaccine design and serodiagnosis.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2012
17. GORCHAKOV R , Wang E, Leal G, Forrester NL, et al
    Attenuation of chikungunya vaccine strain 181/clone 25 is determined by 2 amino acid substitutions in the E2 envelope glycoprotein.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. SEEDHOM MO , Mathurin KS, Kim SK, Welsh RM, et al
    Increased Protection from Vaccinia Virus Infection in Mice Genetically Prone to Lymphoproliferative Disorders.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. GRESETH MD , Boyle KA, Bluma MS, Unger B, et al
    Molecular Genetic and Biochemical Characterization of the Vaccinia Virus I3 Protein, the Replicative SSB.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. JANG YH , Byun YH, Lee YJ, Lee YH, et al
    Cold-adapted pandemic 2009 H1N1 influenza live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. GUZMAN E , Cubillos-Zapata C, Cottingham MG, Gilbert SC, et al
    MVA-based vaccine vectors induce apoptosis in DC draining the skin via both the extrinsic and intrinsic caspase pathways preventing efficient antigen presentation.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. YAMAMOTO T , Johnson MJ, Price DA, Wolinsky DI, et al
    Virus inhibition activity of effector memory CD8+ T cells determines Simian Immunodeficiency Virus load in vaccinated monkeys after vaccine breakthrough infection.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. WHITE SD , Jacobs BL
    THE AMINO TERMINUS OF VACCINIA VIRUS E3 PROTEIN IS NECESSARY TO INHIBIT THE INTERFERON RESPONSE.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. GOMEZ CE , Perdiguero B, Najera JL, Sorzano CO, et al
    Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. FOO CH , Whitbeck JC, Ponce-de-Leon M, Saw WT, et al
    The myristate moiety and amino-terminus of the vaccinia virus L1 constitute a bipartite functional region needed for entry.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. MENG X , Embry A, Rose L, Yan B, et al
    Vaccinia Virus A6 is Essential for Virion Membrane Biogenesis and Localization of Virion Membrane Proteins to Sites of Virion Assembly.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
27. LAU YF , Wright AR, Subbarao K
    The contribution of systemic and pulmonary immune effectors to vaccine-induced protection against H5N1 influenza virus infection.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. SCHROEDER N , Chung CS, Chen CH, Liao CL, et al
    The Lipid Raft-Associated Protein CD98 is Required for Vaccinia Virus Endocytosis.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. COBLEIGH MA , Bradfield C, Liu Y, Mehta A, et al
    The Immune Response to a Vesicular Stomatitis Virus Vaccine Vector is Independent of Particulate Antigen Secretion and Protein Turnover Rate.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. KALANTARI-DEHAGHI M , Chun S, Chentoufi A, Pablo J, et al
    Discovery of potential diagnostic and vaccine antigens in herpes simplex virus-1 and -2 by proteome-wide antibody profiling.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. AWASTHI S , Zumbrun EE, Si H, Wang F, et al
    Live Attenuated Herpes Simplex Virus Type 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. KNUDSEN ML , Mbewe-Mvula A, Rosario M, Johansson DX, et al
    Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to conventional plasmid DNA vaccine.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. BONSIGNORI M , Montefiori DC, Wu X, Chen X, et al
    Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-infected Donor: Implications for Vaccine Design.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. VICTOR ST , Watanabe S, Katsura H, Ozawa M, et al
    A replication-incompetent PB2-knockout influenza A virus vaccine vector.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. ZENG R , Zhang H, Hai Y, Cui Y, et al
    IL-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. SATHESHKUMAR PS , Moss B
    Sequence-divergent chordopoxvirus homologs of the o3 protein maintain functional interactions with components of the vaccinia virus entry-fusion complex.
    J Virol. 2012;86:1696-705.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. SEGUNDO FD , Weiss M, Perez-Martin E, Dias CC, et al
    Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease.
    J Virol. 2012;86:1316-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
38. CHANG SJ , Shih AC, Tang YL, Chang W, et al
    Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. TAKEUCHI K , Nagata N, Kato SI, Ami Y, et al
    Wild-type Measles Virus with the Hemagglutinin Protein of the Edmonston Vaccine Strain Retains Wild-type Tropism in Macaques.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. LI J , Ertel A, Portocarrero C, Barkhouse DA, et al
    Post-exposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the CNS through the rapid induction of genes relevant to adaptive immunity in CNS tissues.
    J Virol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. BENNETT RS , Gresko AK, Nelson JT, Murphy BR, et al
    A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
    J Virol. 2012;86:420-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
42. CHEN Z , Zhou H, Kim L, Jin H, et al
    The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. SCHWENEKER M , Lukassen S, Spath M, Wolferstatter M, et al
    The vaccinia virus O1 protein is required for sustained activation of the extracellular signal-regulated kinase (ERK) 1/2 and promotes viral virulence.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. QURESHI H , Ma ZM, Huang Y, Hodge G, et al
    Low dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus 5 then immunized with a replication defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the Phase IIb Step trial of a similar HIV-1 vaccine.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. LONGET S , Schiller JT, Bobst M, Jichlinski P, et al
    A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection.
    J Virol. 2011;85:13253-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
46. LIETZ R , Bayer W, Ontikatze T, Johrden L, et al
    Co-delivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. CHOU W , Ngo T, Gershon PD
    An overview of the vaccinia virus "Infectome": A survey of the proteins of the poxvirus-infected cell.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. MURAKAMI S , Horimoto T, Ito M, Takano R, et al
    Enhanced growth of influenza vaccine seed viruses in Vero cells mediated by broadening the optimal pH range for virus membrane fusion.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. ISHII H , Kawada M, Tsukamoto T, Yamamoto H, et al
    Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. RUBIN SA , Link MA, Sauder CJ, Zhang C, et al
    Recent mumps outbreaks in vaccinated populations: no evidence of immune escape.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. BRADLEY RR , Lynch DM, Iampietro MJ, Borducchi EN, et al
    Adenovirus Serotype 5 Neutralizing Antibodies Target Both Hexon and Fiber Following Vaccination and Natural Infection.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
52. LORENTE E , Infantes S, Barnea E, Beer I, et al
    MULTIPLE VIRAL LIGANDS NATURALLY PRESENTED BY DIFFERENT CLASS I MOLECULES IN TRANSPORTER ANTIGEN PROCESSING-DEFICIENT VACCINIA VIRUS-INFECTED CELLS.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. PEREIRA AC , Leite FG, Brasil BS, Soares-Martins JA, et al
    A VACCINIA VIRUS-DRIVEN INTERPLAY BETWEEN THE MKK4/7-JNK1/2 PATHWAY AND CYTOSKELETON REORGANIZATION.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. WOLFE CL , Ojeda S, Moss B
    Transcriptional Repression and RNA Silencing Act Synergistically to Demonstrate the Function of the Eleventh Component of the Vaccinia Virus Entry-Fusion Complex.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. POSTIGO A , Way M
    The Vaccinia Virus Encoded Bcl-2 Homologues Do Not Act as Direct Bax Inhibitors.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. VACCARI M , Boasso A, Fenizia C, Fuchs D, et al
    Fatal pancreatitis in SIVmac251 infected macaques treated with 2' ,3' -dideoxyinosine (ddI) and 2' didehydro-3' deoxythymidine(d4T) following CTLA-4 and IDO blockade.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. JURGENS CK , Young K, Madden VJ, Johnson PR, et al
    A Novel Self-Replicating Chimeric Lentivirus-Like Particle.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. RUISS R , Jochum S, Wanner G, Reisbach G, et al
    A VLP-based Epstein-Barr Virus vaccine.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. TERAJIMA M , Cruz J, Co MD, Lee JH, et al
    Complement-Dependent Lysis of Influenza A Virus-Infected Cells by Broadly Cross-Reactive Human Monoclonal Antibodies.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. BIRD BH , Maartens LH, Campbell S, Erasmus BJ, et al
    Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, non-teratogenic, and confers protection from viremia, pyrexia, and abortion following lethal challenge in adult and pregnant sheep.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. DRONIOU-BONZOM ME , Reignier T, Oldenburg JE, Cox AU, et al
    Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. QIN L , Upton C, Hazes B, Evans DH, et al
    Genomic analysis of the vaccinia virus strain variants found in Dryvax vaccine.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. ZHU R , Mancini-Bourgine M, Zhang XM, Bayard F, et al
    Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice.
    J Virol. 2011;85:10201-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. AWASTHI S , Lubinski JM, Shaw CE, Barrett SM, et al
    Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compare
    J Virol. 2011;85:10472-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
65. GONZALEZ-SANTAMARIA J , Campagna M, Garcia MA, Marcos-Villar L, et al
    REGULATION of VACCINIA VIRUS E3 PROTEIN by SUMO.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. BOLLES M , Deming D, Long K, Agnihothram S, et al
    A Double-Inactivated SARS-CoV Vaccine Provides Incomplete Protection In Mice And Induces Increased Eosinophilic Pro-Inflammatory Pulmonary Response Upon Challenge.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. BROWN KS , Safronetz D, Marzi A, Ebihara H, et al
    Vesicular Stomatitis Virus-Based Vaccine Protects Hamsters against Lethal Challenge with Andes Virus.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. MARURI-AVIDAL L , Weisberg AS, Moss B
    Vaccinia Virus L2 Protein Associates with the Endoplasmic Reticulum Near the Growing Edge of Crescent Precursors of Immature Virions and Stabilizes a Subset of Viral Membrane Proteins.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. MYSKIW C , Arsenio J, Hammett C, van Bruggen R, et al
    Comparative analysis of poxvirus orthologues of the Vaccinia Virus E3 protein: Modulation of PKR activity, cytokine responses and virus pathogenicity.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. FENIZIA C , Keele BF, Nichols D, Cornara S, et al
    TRIM5{alpha} does not affect SIVmac251replication in vaccinated or unvaccinated Indian Rhesus Macaques following intrarectal challenge exposure.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. LI H , Liu J, Carville A, Mansfield KG, et al
    Durable, Mucosal SIV-Specific Effector Memory T Lymphocyte Responses Elicited by Recombinant Adenovirus Vectors in Rhesus Monkeys.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. BILELLO JP , Manrique JM, Shin YC, Lauer W, et al
    Vaccine Protection against SIV in Monkeys Using Recombinant {gamma}-2 Herpesvirus.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. CUBILLOS-ZAPATA C , Guzman E, Turner A, Gilbert SC, et al
    Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.
    J Virol. 2011;85:9385-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. WANG E , Kim DY, Weaver SC, Frolov I, et al
    Chimeric Chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response.
    J Virol. 2011;85:9249-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
75. IBRAHIM N , Wicklund A, Wiebe MS
    Molecular Characterization of the Host Defense Activity of Barrier to Autointegration Factor (BAF) Against Vaccinia Virus.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. BODEWES R , Fraaij PL, Geelhoed-Mieras MM, van Baalen CA, et al
    Annual vaccination against influenza hampers development of virus-specific CD8+ T cell immunity in children.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. KHURANA S , Wu J, Verma N, Verma S, et al
    H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies in humans that preferentially bind to oligomeric form of influenza hemagglutinin.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. KANG SM , Yoo DG, Kim MC, Song JM, et al
    MyD88 plays an essential role in inducing B cells capable of differentiating into antibody secreting cells after vaccination.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. LIU J , Chen P, Jiang Y, Wu L, et al
    A Duck Enteritis Virus-vectored Bivalent Live Vaccine Provides Fast and Complete Protection against H5N1 Avian Influenza Virus in Ducks.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. GOMEZ CE , Najera JL, Perdiguero B, Garcia-Arriaza J, et al
    The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional and selective effector memory T cell responses to HIV-1 antigens.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. LU L , Palaniyandi S, Zeng R, Bai Y, et al
    An FcRn-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. BLANEY JE , Wirblich C, Papaneri AB, Johnson RF, et al
    Inactivated or Live-Attenuated Bivalent Vaccines that Confer Protection against Rabies and Ebola Viruses.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. KHATTAR SK , Samal S, Devico AL, Collins PL, et al
    Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in guinea pigs.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. TOP S , Foulon E, Pignolet B, Deplanche M, et al
    Infection of non-host species dendritic cells in vitro with an attenuated myxoma virus induces gene expression predicting efficacy as a vaccine vector.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
85. MATSUO E , Celma CC, Boyce M, Viarouge C, et al
    Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent BTV challenge.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. ALBARINO CG , Bird BH, Chakrabarti AK, Dodd KA, et al
    The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. ZOLLA-PAZNER S , Kong XP, Jiang X, Cardozo T, et al
    CROSS-CLADE HIV-1 NEUTRALIZING ANTIBODIES INDUCED WITH V3-SCAFFOLD PROTEIN IMMUNOGENS FOLLOWING PRIMING WITH gp120 DNA.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. PERREAU M , Welles HC, Harari A, Hall O, et al
    DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell responses in Intestinal Mucosa.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. WINSTONE N , Wilson AJ, Morrow G, Boggiano C, et al
    Enhanced control of pathogenic SIVmac239 replication in macaques immunized with a plasmid IL12 and a DNA prime, viral vector boost vaccine regimen.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. BOSHRA H , Lorenzo G, Busquets N, Brun A, et al
    Rift valley fever: recent insights into pathogenesis and prevention.
    J Virol. 2011;85:6098-105.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
91. CHEN W , Feng Y, Gong R, Zhu Z, et al
    Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogens.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. ZAITSEVA M , Kapnick SM, Meseda CA, Shotwell E, et al
    Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. TAN X , Sande JL, Pufnock JS, Blattman JN, et al
    Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. KECKLER MS , Carroll DS, Gallardo-Romero NF, Lash RR, et al
    Establishment of the Black-Tailed Prairie Dog (Cynomys ludovicianus) as a Novel Animal Model for Comparing Smallpox Vaccines Administered Pre-Exposure in both High and Low-Dose Monkeypox Challenges.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. GE J , Wang X, Tao L, Wen Z, et al
    Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
96. ALDRICH JF , Lowe DB, Shearer MH, Winn RE, et al
    CD4+ T LYMPHOCYTES ARE CRITICAL MEDIATORS OF TUMOR IMMUNITY TO SIMIAN VIRUS 40 LARGE TUMOR ANTIGEN INDUCED BY VACCINATION WITH PLASMID DNA.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. HAI R , Garcia-Sastre A, Swayne DE, Palese P, et al
    A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains.
    J Virol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
98. MCNULTY S , Powell K, Erneux C, Kalman D, et al
    The Host Phosphoinositide 5-Phosphatase SHIP2 Regulates Dissemination of Vaccinia Virus.
    J Virol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
99. KIM DY , Atasheva S, Foy NJ, Wang E, et al
    Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype.
    J Virol. 2011;85:4363-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. BEACH NM , Smith SM, Ramamoorthy S, Meng XJ, et al
     Chimeric porcine circoviruses (PCV) containing amino acid epitope tags in the C terminus of the capsid gene are infectious and elicit both anti-epitope tag antibodies and anti-PCV type 2 neutralizing antibodies in pigs.
     J Virol. 2011;85:4591-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2011
101. SCHELL JB , Rose NF, Bahl K, Diller K, et al
     Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.
     J Virol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. HARVEY R , Guilfoyle KA, Roseby S, Robertson JS, et al
     Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric haemagglutinin molecules.
     J Virol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. YANG Z , Bruno DP, Martens CA, Porcella SF, et al
     Genome-wide Analysis of the 5' and 3' Ends of Vaccinia Virus Early mRNAs Delineates Regulatory Sequences of Annotated and Anomalous Transcripts.
     J Virol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. GAUTAM R , Iyer A, Hunter M, Das A, et al
     VSV-SRV-2 vaccine protects macaques from detectable infection and B-cell destruction.
     J Virol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. PETTERSEN FO , Torheim EA, Dahm AE, Aaberge IS, et al
     An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: Downregulated immune activation and improved T cell-dependent vaccine responses.
     J Virol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. MORNER A , Jansson M, Bunnik EM, Scholler J, et al
     Immunization with Recombinant HLA Class I and II, HIV-1 gp140 and SIV p27 Elicits Protection against Heterologous SHIV Infection in Rhesus Macaques.
     J Virol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. LOUSBERG EL , Diener KR, Fraser CK, Phipps S, et al
     Antigen-specific T-cell responses to a recombinant fowlpox virus are dependent on MyD88 and interleukin-18 and independent of Toll-like receptor 7 (TLR7)- and TLR9-mediated innate immune recognition.
     J Virol. 2011;85:3385-96.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2011
108. MALHERBE DC , Doria-Rose NA, Misher L, Beckett T, et al
     Sequential immunization with a subtype B HIV-1 Envelope quasispecies partially mimics the in vivo development of neutralizing antibodies.
     J Virol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. JOHNSON PL , Kochin BF, McAfee MS, Stromnes IM, et al
     Vaccination alters the balance between protective immunity, exhaustion, escape and death in chronic infections.
     J Virol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. PASCUTTI MF , Rodriguez AM, Falivene J, Giavedoni L, et al
     INTERPLAY BETWEEN MODIFIED VACCINIA VIRUS ANKARA AND DENDRITIC CELLS: PHENOTYPIC AND FUNCTIONAL MATURATION OF BYSTANDER DENDRITIC CELLS.
     J Virol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2011
111. MORELLO CS , Levinson MS, Kraynyak KA, Spector DH, et al
     Immunization with Herpes Simplex Virus Type 2 (HSV-2) Genes Plus Inactivated HSV-2 Is Highly Protective Against Acute and Recurrent HSV-2 Disease.
     J Virol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2010
112. MAAMARY J , Array F, Gao Q, Garcia-Sastre A, et al
     Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag specific immune response in mice.
     J Virol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: